Compare AbCellera Biologics Inc (ABCL) vs Aegon Ltd. (AEG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Aegon Ltd. — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while Aegon Ltd. trades at $8.73 (market cap $12.98B). The key difference: Aegon Ltd. is far larger — about 5.5× AbCellera Biologics Inc's market cap, and Aegon Ltd. pays a 5.3% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | AEG | |
|---|---|---|
Market Cap | $2.35B | $12.98B |
Sector | Health | Financials |
52-Week High | $8.12 | $8.79 |
52-Week Low | $2.78 | $6.79 |
Enterprise Value | $1.99B | $14.11B |
Dividend Yield | — | 5.3% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Aegon Ltd.
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →
